Truthout
Drug Pricing
Trump’s Attack on Medicare for All Has Industry Fingerprints All Over It
It’s no surprise that the health insurance industry went right to the White House.
Drug Makers Play the Patent Game to Lock in Prices, Block Competitors
No industry gets a greater financial return from its patent strategy than pharmaceuticals.
Hepatitis C Patients Are Being Forced Into Underground Buyers’ Clubs
Access to medication and treatment is a huge issue for hepatitis patients in the United States.
UCLA’s Patent War in India Prevents Access to Prostate Cancer Treatment
Prostate cancer patients from low-income areas where a life-saving drug was tested can no longer afford it.
Activists With Diabetes Take on the Global Insulin Crisis
T1 International has flipped the script on health care advocacy with patients leading the fight for accessible insulin.
State Prisons Fail to Offer Cure to 144,000 Prisoners With Deadly Hepatitis C
Many states cited high drug prices as the reason for denying treatment.
Big Pharma Cozies Up to Trump as He Moves to Lower Drug Prices
Big pharma is blaming others in the drug supply chain while pushing policies to protect its own bottom line.
Trump’s Angry Tweets and Secret Deals Will Not Lower Drug Prices
A secret deal to delay price hikes is not the same as lowering prices. But Trump and the GOP won't consider regulation.
Despite Trump’s Promises, Drug Prices Are Not Dropping Yet
Drug makers have raised prices during Trump's tenure and show no signs of changing course.
Benefit Change Could Raise Costs for Patients Getting Drug Co-Pay Assistance
Drug copay assistance programs have long been controversial.